192 related articles for article (PubMed ID: 32316888)
1. Human Papillomavirus Induced Cervical and Oropharyngeal Cancers: From Mechanisms to Potential Immuno-therapeutic Strategies.
Saeed M; Faisal SM; Akhtar F; Ahmad S; Alreshidi MM; Kausar MA; Kazmi S; Saeed A; Adnan M; Ashraf GM
Curr Drug Metab; 2020; 21(3):167-177. PubMed ID: 32316888
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
3. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers.
Zhang L; Zhou F; Zhao KN
Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116
[TBL] [Abstract][Full Text] [Related]
4. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
Valdespino-Gómez VM
Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus in cervical and head-and-neck cancer.
Psyrri A; DiMaio D
Nat Clin Pract Oncol; 2008 Jan; 5(1):24-31. PubMed ID: 18097454
[TBL] [Abstract][Full Text] [Related]
6. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
Otter S; Whitaker S; Chatterjee J; Stewart A
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):81-90. PubMed ID: 30385006
[TBL] [Abstract][Full Text] [Related]
7. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.
Best SR; Niparko KJ; Pai SI
Otolaryngol Clin North Am; 2012 Aug; 45(4):807-22. PubMed ID: 22793854
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
Morand GB; Cardona I; Cruz SBSC; Mlynarek AM; Hier MP; Alaoui-Jamali MA; da Silva SD
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955529
[TBL] [Abstract][Full Text] [Related]
9. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
12. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.
Tornesello ML; Perri F; Buonaguro L; Ionna F; Buonaguro FM; Caponigro F
Cancer Lett; 2014 Sep; 351(2):198-205. PubMed ID: 24971935
[TBL] [Abstract][Full Text] [Related]
13. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
14. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
Mehra R; Ang KK; Burtness B
Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
[TBL] [Abstract][Full Text] [Related]
15. HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and Treatment.
Trimble CL
Cancer Immunol Res; 2014 Oct; 2(10):937-42. PubMed ID: 25281321
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in immunotherapy of cancers caused by human papillomaviruses.
Fakhr E; Modic Ž; Cid-Arregui A
Immunology; 2021 May; 163(1):33-45. PubMed ID: 33205441
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus and the Development of Different Cancers.
Gao G; Smith DI
Cytogenet Genome Res; 2016; 150(3-4):185-193. PubMed ID: 28245440
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus-related oropharyngeal cancer.
Taberna M; Mena M; Pavón MA; Alemany L; Gillison ML; Mesía R
Ann Oncol; 2017 Oct; 28(10):2386-2398. PubMed ID: 28633362
[TBL] [Abstract][Full Text] [Related]
19. Role of the Common Fragile Sites in Cancers with a Human Papillomavirus Etiology.
Gao G; Smith DI
Cytogenet Genome Res; 2016; 150(3-4):217-226. PubMed ID: 28142148
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
